HIV treatment involves combinations of antiretroviral medicines designed to prevent the virus from multiplying. NRTIs are among the foundational drug classes used in many treatment regimens. They target reverse transcriptase, an HIV enzyme involved in converting viral RNA into DNA, thereby helping reduce viral replication.
NRTIs act as building block analogues that interfere with the process HIV uses to create DNA. After entering cells, these medicines are activated and can become incorporated into the growing viral DNA chain. This prevents the virus from efficiently completing DNA production.
Common NRTIs include:
NRTIs are generally not used alone for HIV treatment. Combining medicines from different antiretroviral classes helps suppress HIV more effectively and lowers the risk of resistance.
NRTIs have played a major role in the development of effective combination antiretroviral therapy. Modern treatment commonly uses an NRTI backbone together with medicines from another antiretroviral class, depending on individual clinical factors and current treatment recommendations.
Important considerations include:
NRTIs remain an important part of HIV treatment and have contributed substantially to the effectiveness of modern antiretroviral therapy. Although individual medicines differ in their properties and safety considerations, their shared role is to interfere with HIV reverse transcriptase and help prevent viral replication. Treatment choices should always be made with a qualified healthcare professional based on current clinical guidelines and individual circumstances. This article is intended for general information only and does not provide medical diagnosis, treatment, sales, or service information.